LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) said that it agreed to buy all outstanding equity of Neogene Therapeutics for a total consideration of up to $320 million, on a cash and debt free
(Reuters) -AstraZeneca said on Tuesday it would acquire Neogene Therapeutics, a developer of cell-based cancer treatments, for up to $320 million, as .
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
London Stocks Seen Higher as Asia Gains on China Hopes morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Jeito Capital, Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics